Biotech News

CellCentric lands $120M to power clinical trials of oral cancer drug inobrodib

Despite major progress in treating multiple myeloma, a significant number of patients continue to face relapse or resistance to existing therapies. Many are not eligible for high-intensity treatments,...

Last updated 3 mins ago